pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,696 catalysts · 6,366 phase readout · 2,324 8k filing · 389 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 33 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,366
  • 8k filing2,324
  • earnings389
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07749469: Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin

Sponsor: USMARI Research & Innovation Centre. Phase: NA. Conditions: Acne

full page →ctgov ↗
›RECRUITINGphase readoutNCT06651983: Association of Inflammatory Factors With Complications in the Diabetic Population: a Cross-sectional Study

Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT05797441: Testing the Effectiveness of a Therapist-Assisted Self-Management Program for Veterans Who Finished PTSD Therapy

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: PTSD, Post Traumatic Stress Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT05713669: Impact of Resident Participation in Post-ICU Follow Up Clinic

Sponsor: University of Michigan. Phase: NA. Conditions: Professional Burnout

full page →ctgov ↗
›RECRUITINGphase readoutNCT07597083: Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer Survivors

Sponsor: Beni-Suef University. Phase: NA. Conditions: Cervical Cancer, Female Sexual Dysfunction (FSD), Radiation Induced Pelvic Floor Muscle Dysfunction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07376083: Ultrasound vs Chest X-ray for NG Tube Placement in ICU

Sponsor: Tepecik Training and Research Hospital. Phase: . Conditions: Intensive Care (ICU)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07660341: SAD Study of CGB3002 in Healthy Participants

Sponsor: ChainGen Biopharma Ltd. Phase: PHASE1. Conditions: Alzheimer s Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05690841: FocaL Mass Drug Administration for Vivax Malaria Elimination

Sponsor: University of California, San Francisco. Phase: PHASE3. Conditions: Plasmodium Vivax Malaria, Malaria

full page →ctgov ↗
›RECRUITINGphase readoutNCT05822141: Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure

Sponsor: Indiana University. Phase: NA. Conditions: Cold Exposure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07296341: HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Locally Advanced or Metastatic Pancreatic Cancer With

full page →ctgov ↗
›COMPLETEDphase readoutNCT07204483: Feasibility Trial of Functional Clothing, Moderate Exercise, and Health Information for Stress Reduction and Behavior Change in Okinawa

Sponsor: Shinyu Kise. Phase: NA. Conditions: Obesity, Metabolic Syndrome, Stress, Psychological

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07707583: Heart Rate Variability and Medication Adherence in Resistant Hypertension

Sponsor: Nemocnice AGEL Trinec-Podlesi a.s.. Phase: . Conditions: Resistant Hypertension, Medication Adherence, Autonomic Nervous System

full page →ctgov ↗
›COMPLETEDphase readoutNCT03652441: Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma

Sponsor: University of Cologne. Phase: PHASE2. Conditions: Classical Hodgkin Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05296954: Localization of Anatomical Structures Involved in Nodal Tachycardias by High Density Mapping.

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Atrioventricular Nodal Reentry Tachycardia, Supraventricular Tachycardia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06255041: Detection of Cancer in Breath Samples by Trained Detection Dogs

Sponsor: SpotitEarly. Phase: . Conditions: Breast Cancer, Colorectal Cancer, PROSTATE CANCER, Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05515354: Smoking Cessation and Menstrual Cycle Phase

Sponsor: Centre for Addiction and Mental Health. Phase: PHASE4. Conditions: Nicotine Dependence, Tobacco Smoking, Smoking Cessation, Nicotine Use Disorder, Substance Use Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT03343769: Study of the Relationship Between the Strength of Ankle Movement Muscles and Postural Parameters in Elderly Fallers: Towards New Strategies for Screening and Management

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Persons Who Have Experienced a Sudden Uncontrolled Fall in the Absence of Outside Factors in the 6 Months Preceding the Consultation

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06940869: Network to Understand Reproductive Rheumatology Registry

Sponsor: Duke University. Phase: . Conditions: Rheumatic Diseases, Pregnancy Related, Pregnancy Interest, Reproductive Health, Autoimmune Diseases

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07397273: Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.

Sponsor: Northern Illinois University. Phase: NA. Conditions: Healthy Adult Participants

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04792073: Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Merkel Cell Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04071769: Genentech Xenon MRI Idiopathic Pulmonary Fibrosis

Sponsor: Duke University. Phase: PHASE2. Conditions: Idiopathic Pulmonary Fibrosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03266783: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Sponsor: Ottawa Hospital Research Institute. Phase: PHASE4. Conditions: Venous Thromboembolism

full page →ctgov ↗
›COMPLETEDphase readoutNCT03376269: HBOT Effect on Chronic Pain Syndrome With a History of Psychological Trauma

Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Fibromyalgia, Chronic Pain Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07558070: Effect of Teach-Back-Based Discharge Education in Lower Extremity Surgery Patients

Sponsor: University of Gaziantep. Phase: NA. Conditions: Lower Extremity Surgery, Patient Education, Postoperative Care

full page →ctgov ↗
›RECRUITINGphase readoutNCT07479173: Effects of P24 on Postprandial Aminoacidemia

Sponsor: Amplifye. Phase: NA. Conditions: Postprandial Amino Acid Concentrations in Healthy Adults

full page →ctgov ↗
›RECRUITINGphase readoutNCT02328573: The Impact of Group Singing on Patients With Stroke and Their Personal Caregivers

Sponsor: Icahn School of Medicine at Mount Sinai. Phase: NA. Conditions: Stroke and Aphasia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07730073: Efficacy of LSVT-LOUD Therapy on Voice, Speech, and Quality of Life in Parkinson's Disease

Sponsor: Atlas University. Phase: NA. Conditions: Parkinson's Disease (PD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05319873: Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE1. Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Locally Advanced HER2-Positive Breast Carcinoma, Metastatic HER2-Positive Breast Carcinoma, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8

full page →ctgov ↗
›RECRUITINGphase readoutNCT06502873: Setting up a Cohort of Patients With Inflammatory Bowel Disease and a Cohort of Patients Without Chronic Inflammatory Bowel Disease

Sponsor: Artialis. Phase: NA. Conditions: Inflammatory Bowel Disease (IBD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07222969: A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

Sponsor: Vibrant Sciences Limited. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT06179069: A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Sponsor: Zai Lab (Shanghai) Co., Ltd.. Phase: PHASE1. Conditions: SCLC

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07666269: Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical Diagnosis

Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Osteogenesis Imperfecta, Rare Bone Disorders, Hypophosphatemia, X-Linked, Mucopolysaccharidoses, Tooth Abnormalities, Palate; Deformity, Artificial Intelligence (AI), Machine Learning

full page →ctgov ↗
›RECRUITINGphase readoutNCT06839469: Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Sponsor: Columbia University. Phase: . Conditions: Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy (DMD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07476183: Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia

Sponsor: Apriligen, Inc.. Phase: PHASE1. Conditions: RPS19 Deficient Diamond-Blackfan Anemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07404683: Safety and Effects of High-Intensity Blood Flow Restriction Training in the Rotator Cuff

Sponsor: University of Valencia. Phase: NA. Conditions: Healthy Adult

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07665541: TASK-ORIENTED REHABILITATION AFTER ROTATOR CUFF SURGERY

Sponsor: Medipol University. Phase: NA. Conditions: Rotator Cuff Tear Repair

full page →ctgov ↗
›COMPLETEDphase readoutNCT04290741: Emergency Department Acupuncture for Acute Musculoskeletal Pain Management

Sponsor: Duke University. Phase: NA. Conditions: Musculoskeletal Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT00912041: BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

Sponsor: Leigh R. Hochberg, MD, PhD.. Phase: NA. Conditions: Tetraplegia, Spinal Cord Injuries, Amyotrophic Lateral Sclerosis, Brain Stem Infarctions, Locked in Syndrome, Muscular Dystrophy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02324387: Tc99m Sestamibi Molecular Breast Imaging

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06307093: Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

Sponsor: R-Pharm. Phase: PHASE1. Conditions: Skin Melanoma, Squamous Non-small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT04463121: Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06)

Sponsor: BackBeat Medical Inc. Phase: NA. Conditions: Bradycardia, Hypertension, Systolic

full page →ctgov ↗
›COMPLETEDphase readoutNCT07017621: Qualitative Study on the Experiences of Mothers 6 to 12 Months After Their Participation in the Mother-baby Groups of the HUGS Study

Sponsor: University Hospital, Toulouse. Phase: . Conditions: Postnatal Depression, Postpartum Depression (PPD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06368414: A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia

Sponsor: Korean Society of Hematology. Phase: PHASE2. Conditions: Chronic Myeloid Leukemia, Chronic Phase

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05711316: The BD Liverty™ TIPS Stent Graft Study

Sponsor: C. R. Bard. Phase: NA. Conditions: Portal Hypertension, TIPS

full page →ctgov ↗
›COMPLETEDphase readoutNCT07455825: A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT07700576: Effects of Different Nap Durations on Volleyball Performance and EEG Activity Following Mental Fatigue

Sponsor: Inonu University. Phase: NA. Conditions: Mental Fatigue, Recovery, Volleyball, Sport Performance

full page →ctgov ↗
›RECRUITINGphase readoutNCT07687576: Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study

Sponsor: Oxford University Hospitals NHS Trust. Phase: PHASE2. Conditions: STEMI - ST Elevation Myocardial Infarction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07505576: Anti-alpha-actinin Antibodies and Lupus Nephritis Activity

Sponsor: Assiut University. Phase: . Conditions: Lupus Nephritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06090240: Motivational Interviewing to Enhance Advance Care Planning for Older Adults and Caregivers After Emergency Visits

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Older Adults, Advance Care Planning, Advance Directives, Family Members

full page →ctgov ↗
›RECRUITINGphase readoutNCT05636540: In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

Sponsor: Heather Wachtel. Phase: EARLY_PHASE1. Conditions: Pheochromocytoma, Paraganglioma

full page →ctgov ↗
← prev
page 168 of 174
next →